SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-09-070639
Filing Date
2009-04-01
Accepted
2009-04-01 16:05:49
Documents
5
Effectiveness Date
2009-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm DEFA14A 55259
2 SETTLEMENT AGREEMENT - SIGMA-TAU dex101.htm EX-10.1 55751
3 ZADAXIN AGREEMENT - SIGMA-TAU INDUSTRIE FARMACEUTICHE REUNITE SPA dex102.htm EX-10.2 8757
4 PRESS RELEASE dex991.htm EX-99.1 17520
5 GRAPHIC g26358g75d12.jpg GRAPHIC 16480
  Complete submission text file 0001193125-09-070639.txt   161582
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19825 | Film No.: 09723430
SIC: 2834 Pharmaceutical Preparations